Neptune Medical, the parent company of Triton Medical Robotics, has appointed a new board chair — and he’s well-known in surgical robotics.

Dr. Fred Moll co-founded surgical robotics pioneer Intuitive in 1995. In recent years, he led robotic surgery developer Auris Health to its $3.4 billion sale to Johnson & Johnson in 2019. He’s presently a managing partner at healthcare technology venture capital firm Sonder Capital — and is board chair at Procept BioRobotics and Moon Surgical. He’s also a board member at Shockwave Medical.

“We are thrilled to welcome Dr. Fred Moll as the chairman of the board at Neptune Medical,” Alex Tilson, the company’s founder and CEO, said in a news release. “His unparalleled experience in the medical technology sector will be invaluable as we continue to grow and advance our mission of transforming healthcare with innovative products.”

Neptune Medical is a Burlingame, California–based startup with proprietary Dynamic Rigidization technology that can instantly toggle thin-walled tubes — such as overtubes, catheters or cannulae — between flexible and rigid states. The technology is already used in Neptune Medical’s FDA-cleared Pathfinder advanced endoscopy device, which the company says is used in a growing number of U.S. hospitals and academic medical centers.

Meanwhile, Neptune Medical’s Triton Medical Robotics division is taking the Dynamic Rigidization technology and using it to develop a fully flexible medical robot to enable doctors to reach deep into human anatomy. Triton’s website says that company officials think their robot will disrupt flexible endoscopy and set a new standard in outcomes.

In Neptune Medical’s latest news release, Moll said: “I am excited about the opportunity to work with the talented team at Neptune Medical and contribute to the development of groundbreaking medical technologies that have the potential to make a significant impact on patient care.”